HK1041884A1 - Tan-1057衍生物 - Google Patents

Tan-1057衍生物

Info

Publication number
HK1041884A1
HK1041884A1 HK02103758.4A HK02103758A HK1041884A1 HK 1041884 A1 HK1041884 A1 HK 1041884A1 HK 02103758 A HK02103758 A HK 02103758A HK 1041884 A1 HK1041884 A1 HK 1041884A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
tan
disorders
humans
animals
Prior art date
Application number
HK02103758.4A
Other languages
English (en)
Inventor
Brands Michael
Es-Sayed Mazen
Habich Dieter
Raddatz Siegfried
Kruger Joachim
Endermann Rainer
Gahlmann Reinhold
Kroll Hein-Peter
Geschke Frank-Ulrich
Demeijere Armin
N Belov Vladimir
Sokolov Victor
Kozhushkov Sergej
Kordes Markus
Original Assignee
拜爾公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 拜爾公司 filed Critical 拜爾公司
Publication of HK1041884A1 publication Critical patent/HK1041884A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
HK02103758.4A 1998-08-27 2002-05-17 Tan-1057衍生物 HK1041884A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19838998A DE19838998A1 (de) 1998-08-27 1998-08-27 Neue Naturstoffderivate
PCT/EP1999/006124 WO2000012484A1 (de) 1998-08-27 1999-08-20 Tan-1057 derivate

Publications (1)

Publication Number Publication Date
HK1041884A1 true HK1041884A1 (zh) 2002-07-26

Family

ID=7878913

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103758.4A HK1041884A1 (zh) 1998-08-27 2002-05-17 Tan-1057衍生物

Country Status (25)

Country Link
US (1) US6617332B1 (zh)
EP (1) EP1117652B1 (zh)
JP (1) JP4533535B2 (zh)
KR (1) KR20010099629A (zh)
CN (1) CN1324348A (zh)
AT (1) ATE267816T1 (zh)
AU (1) AU759618B2 (zh)
BG (1) BG105275A (zh)
BR (1) BR9913337A (zh)
CA (1) CA2342102C (zh)
DE (2) DE19838998A1 (zh)
EE (1) EE200100125A (zh)
ES (1) ES2219105T3 (zh)
HK (1) HK1041884A1 (zh)
HR (1) HRP20010135A2 (zh)
HU (1) HUP0103316A3 (zh)
ID (1) ID28365A (zh)
IL (1) IL141325A0 (zh)
NO (1) NO20010940L (zh)
NZ (1) NZ510153A (zh)
PL (1) PL346143A1 (zh)
SK (1) SK2622001A3 (zh)
TR (1) TR200100637T2 (zh)
WO (1) WO2000012484A1 (zh)
ZA (1) ZA200101038B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1113008A1 (en) * 1999-12-29 2001-07-04 Pfizer Products Inc. 4-oxo-2-ureido-1,4,5,6-tetrahydro-pyrimidine derivatives useful as antibacterial and antiprotozoal agents
US20040204404A1 (en) * 2002-09-30 2004-10-14 Robert Zelle Human N-type calcium channel blockers
EP2679590A1 (en) * 2007-12-20 2014-01-01 Dr. Reddy's Laboratories Ltd. Processes for the Preparation of Sitagliptin and Pharmaceutically acceptable Salts thereof
US8487126B2 (en) 2009-10-15 2013-07-16 The University Of Tokushima Process for preparation of diethylenetriaminepentaacetic acid derivative, and diethylenetriaminepentaacetic acid derivative
CN102725274A (zh) 2009-10-16 2012-10-10 Rib-X制药公司 抗微生物化合物和其制备和使用方法
ES2675798T3 (es) 2009-10-16 2018-07-12 Melinta Therapeutics, Inc. Compuestos antimicrobianos y métodos para fabricar y usar los mismos
CN104628729B (zh) * 2009-10-16 2018-11-06 梅琳塔治疗公司 抗微生物化合物和其制备和使用方法
MX359743B (es) 2009-10-16 2018-10-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos para fabricar y utilizar los mismos.
ES2665988T3 (es) 2011-04-15 2018-04-30 Melinta Therapeutics, Inc. Compuestos antimicrobianos y métodos de fabricación y uso de los mismos
RU2475479C1 (ru) * 2011-12-23 2013-02-20 Федеральное государственное бюджетное учреждение Министерства здравоохранения и социального развития Российской Федерации "Медицинский радиологический научный центр" (ФГБУ МРНЦ Минздравсоцразвития России) Вазоконстрикторное средство
MX2016003046A (es) 2013-09-09 2016-09-08 Melinta Therapeutics Inc Compuestos antimicrobianos y métodos de fabricación y utilización de los mismos.
KR20160070066A (ko) 2013-09-09 2016-06-17 멜린타 테라퓨틱스, 인크. 항균 화합물, 및 이의 제조 방법 및 이용 방법
BR112017019349A2 (pt) 2015-03-11 2018-06-05 Melinta Therapeutics Inc compostos antimicrobianos e métodos de fabricação e uso dos mesmos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2873340B2 (ja) * 1988-04-29 1999-03-24 武田薬品工業株式会社 抗生物質ｔａｎ―１０５７，その製造法および用途
US6110925A (en) 1997-08-07 2000-08-29 Research Corporation Technologies, Inc. Antibiotic for methicillin resistant bacteria

Also Published As

Publication number Publication date
US6617332B1 (en) 2003-09-09
JP2002523496A (ja) 2002-07-30
EE200100125A (et) 2002-06-17
BG105275A (en) 2001-11-30
HRP20010135A2 (en) 2002-02-28
AU1009900A (en) 2000-03-21
IL141325A0 (en) 2002-03-10
NO20010940D0 (no) 2001-02-23
KR20010099629A (ko) 2001-11-09
SK2622001A3 (en) 2001-11-06
EP1117652B1 (de) 2004-05-26
JP4533535B2 (ja) 2010-09-01
ES2219105T3 (es) 2004-11-16
WO2000012484A1 (de) 2000-03-09
DE19838998A1 (de) 2000-03-09
NZ510153A (en) 2002-12-20
CA2342102C (en) 2008-10-28
PL346143A1 (en) 2002-01-28
NO20010940L (no) 2001-04-23
TR200100637T2 (tr) 2001-10-22
ZA200101038B (en) 2002-02-07
ID28365A (id) 2001-05-17
AU759618B2 (en) 2003-04-17
EP1117652A1 (de) 2001-07-25
DE59909607D1 (de) 2004-07-01
BR9913337A (pt) 2001-05-15
HUP0103316A3 (en) 2002-06-28
HUP0103316A2 (hu) 2002-04-29
ATE267816T1 (de) 2004-06-15
CN1324348A (zh) 2001-11-28
CA2342102A1 (en) 2000-03-09

Similar Documents

Publication Publication Date Title
MY124122A (en) Heterocyclic derivatives
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
IL162214A0 (en) Pyridine derivatives and pharmaceutical compositions containing the same
NZ284846A (en) 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
BG105588A (en) Anthranilic acide amides and the use thereof as medicaments
CR6540A (es) Trifluorobutenos nematicidas
PL367682A1 (en) Dolastatin 10 derivatives
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
AP2000001947A0 (en) Novel crystalline forms of an antiviral benzidazole compound.
GB9715894D0 (en) Heterocyclic derivatives
MY115211A (en) Novel amino acid derivatives, their preparation and use
CA2415354A1 (en) Phospholipid derivatives of valproic acid and mixtures thereof
IL141325A0 (en) Tan-1057 derivatives
UA49884C2 (uk) ПОХІДНІ <font face="Symbol">a</font>-ГІДРОКСИКАРБОНОВОЇ КИСЛОТИ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
BG106155A (en) Novel derivatives and analogues of galanthamin
GB9809349D0 (en) Heterocyclic derivatives
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
MXPA04005552A (es) Analogos de vitamina d.
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
PT1427417E (pt) Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
IL162314A (en) Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides, processes for their preparation, pharmaceutical compositions comprising them and uses thereof
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
SI1196129T1 (sl) Farmacevtski in kozmeticni sestavki, ki obsegajo derivate urokaninske kisline kot odstranjevalce radikalov ali antioksidante
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
PL355113A1 (en) Novel fusidic acid derivatives